Cytokinetics Announces Completion of Enrollment in GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

Ads

You May Also Like

Innate Pharma announces its financial calendar for 2017

INNATE PHARMA ANNOUNCES ITS FINANCIAL CALENDAR FOR 2017 Marseille, France, January 4, 2017 Innate ...